森萱医药
(830946)
| 流通市值：50.10亿 | | | 总市值：50.12亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 537,868,689.73 | 583,318,157.66 | 657,357,000.25 | 533,026,389.27 |
| 应收票据及应收账款 | 60,695,494.42 | 72,149,925.79 | 57,690,012.98 | 70,672,389.55 |
| 其中：应收票据 | 10,373,736.88 | 13,297,961.71 | 11,187,769.67 | 9,967,464.58 |
| 应收账款 | 50,321,757.54 | 58,851,964.08 | 46,502,243.31 | 60,704,924.97 |
| 应收款项融资 | 28,760,907.04 | 28,537,550.48 | 31,877,699.06 | 34,523,046.38 |
| 预付款项 | 5,707,783.24 | 2,750,262.07 | 3,343,230.46 | 3,848,294.64 |
| 其他应收款合计 | 184,931.66 | 203,001.93 | 286,412.72 | 247,904.33 |
| 存货 | 119,135,520.81 | 120,847,737.8 | 140,476,004.39 | 143,082,137.18 |
| 一年内到期的非流动资产 | - | - | - | 46,451,166.65 |
| 其他流动资产 | 143,263.72 | 135,165.75 | 117,013.51 | 32,197.51 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 890,046,955.31 | 863,020,294.53 | 931,459,373.37 | 912,009,914.4 |
| 非流动资产: | | | | |
| 固定资产 | 329,161,523.78 | 312,441,232.37 | 320,782,243.59 | 331,132,047.5 |
| 在建工程 | 997,169.82 | 24,256,837.56 | 27,121,420.39 | 26,779,321.27 |
| 使用权资产 | 1,021,980.27 | 1,412,859.13 | 1,960,593.54 | 2,390,686.29 |
| 无形资产 | 35,328,106.99 | 35,620,177.57 | 35,918,990.46 | 36,217,803.37 |
| 递延所得税资产 | 5,351,690.22 | 5,317,521.94 | 6,078,068.46 | 5,748,288.62 |
| 其他非流动资产 | 112,786,630.14 | 112,088,821.92 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 484,647,101.22 | 491,137,450.49 | 391,861,316.44 | 402,268,147.05 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,374,694,056.53 | 1,354,157,745.02 | 1,323,320,689.81 | 1,314,278,061.45 |
| 流动负债: | | | | |
| 短期借款 | - | - | 4,005,666.71 | 15,016,666.71 |
| 应付票据及应付账款 | 30,897,076.1 | 30,898,316.4 | 33,105,835.01 | 32,844,482.81 |
| 应付账款 | 30,897,076.1 | 30,898,316.4 | 33,105,835.01 | 32,844,482.81 |
| 合同负债 | 4,970,695.32 | 4,565,786.52 | 3,526,428.65 | 3,236,947.51 |
| 应付职工薪酬 | 15,548,097 | 23,457,068.06 | 20,540,407.79 | 17,434,875.7 |
| 应交税费 | 8,953,807.9 | 10,660,394.92 | 6,717,595.92 | 10,091,333.32 |
| 其他应付款合计 | 5,183,864.01 | 6,105,517.66 | 6,911,255.12 | 8,795,457.54 |
| 应付股利 | - | - | - | 2,000,000 |
| 一年内到期的非流动负债 | 999,416.31 | 1,237,109.83 | 1,618,016.88 | 1,628,624.32 |
| 其他流动负债 | 5,845,037.49 | 6,866,083.47 | 5,524,016.18 | 6,159,646.38 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 72,397,994.13 | 83,790,276.86 | 81,949,222.26 | 95,208,034.29 |
| 非流动负债: | | | | |
| 租赁负债 | - | - | 83,913.54 | 825,199.82 |
| 递延收益 | 2,269,821.69 | 2,323,827.51 | 2,345,477.92 | 2,418,897.04 |
| 递延所得税负债 | 3,238,250.02 | 3,126,040.74 | 4,902,446.58 | 4,642,288.64 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,508,071.71 | 5,449,868.25 | 7,331,838.04 | 7,886,385.5 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 77,906,065.84 | 89,240,145.11 | 89,281,060.3 | 103,094,419.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 426,918,340 | 426,918,340 | 426,918,340 | 426,918,340 |
| 资本公积 | 217,559,039.68 | 217,559,039.68 | 217,559,039.68 | 217,559,039.68 |
| 专项储备 | 2,842,363.3 | 1,420,641 | 2,545,989.41 | 2,469,831.44 |
| 盈余公积 | 49,089,945.29 | 49,089,945.29 | 42,041,795.43 | 42,041,795.43 |
| 未分配利润 | 525,409,670.55 | 496,377,191.59 | 471,032,142.57 | 449,346,064.06 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,221,819,358.82 | 1,191,365,157.56 | 1,160,097,307.09 | 1,138,335,070.61 |
| 少数股东权益 | 74,968,631.87 | 73,552,442.35 | 73,942,322.42 | 72,848,571.05 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,296,787,990.69 | 1,264,917,599.91 | 1,234,039,629.51 | 1,211,183,641.66 |
| 负债和股东权益合计 | 1,374,694,056.53 | 1,354,157,745.02 | 1,323,320,689.81 | 1,314,278,061.45 |
| 公告日期 | 2025-04-29 | 2025-04-14 | 2024-10-29 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |